US 12,291,523 B2
LXR modulators with bicyclic core moiety
Christian Gege, Ehingen (DE); Olaf Kinzel, Heidelberg (DE); Eva Hambruch, Mannheim (DE); Manfred Birkel, Seeheim-Jugenheim (DE); Claus Kremoser, Heidelberg (DE); and Ulrich Deuschle, Speyer (DE)
Assigned to ORSOBIO, INC., Menlo Park, CA (US)
Filed by OrsoBio, Inc., Menlo Park, CA (US)
Filed on Mar. 5, 2024, as Appl. No. 18/596,586.
Application 18/166,831 is a division of application No. 17/255,821, granted, now 11,618,747, issued on Apr. 4, 2023, previously published as PCT/EP2019/067351, filed on Jun. 28, 2019.
Application 18/596,586 is a continuation of application No. 18/166,831, filed on Feb. 9, 2023, granted, now 11,970,484.
Claims priority of application No. 18180450 (EP), filed on Jun. 28, 2018.
Prior Publication US 2024/0317726 A1, Sep. 26, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 409/14 (2006.01); A61P 1/16 (2006.01); C07D 209/18 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 405/04 (2006.01); C07D 405/10 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 451/02 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01)
CPC C07D 409/14 (2013.01) [A61P 1/16 (2018.01); C07D 209/18 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 451/02 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07B 2200/05 (2013.01)] 2 Claims
 
1. A compound that is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.
 
2. A compound that is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.